news

19 April 2026

Crownz Attends ICBC Berlin 2026 – Europe's Leading Medical Cannabis Conference

Berlin, Germany | 13–15 April 2026

The International Cannabis Business Conference (ICBC) Berlin 2026 once again brought together professionals from across the global medical cannabis industry, reaffirming its reputation as Europe's leading business event dedicated to cannabis, pharmaceuticals, and healthcare innovation. Members of the Crownz team attended the conference to meet industry leaders, strengthen existing relationships, and explore new opportunities within the rapidly evolving European medical cannabis market.

Connecting with the Global Medical Cannabis Community

Held at the Estrel Berlin Hotel, ICBC Berlin welcomed thousands of attendees representing every stage of the medical cannabis supply chain. The event brought together healthcare professionals, pharmaceutical companies, licensed producers, distributors, technology providers, investors, and regulatory experts from around the world. With Germany continuing to play a central role in the European medical cannabis sector, this year's conference focused on the latest regulatory developments, pharmaceutical standards, market growth, and innovations that are shaping the future of patient care.

Crownz at ICBC Berlin

Attending ICBC provided an excellent opportunity for our team to engage directly with companies and professionals operating across the international medical cannabis industry. Throughout the event, we held discussions with:

- Medical cannabis manufacturers

- Pharmaceutical wholesalers and distributors

- Healthcare technology providers

- Compliance and regulatory specialists

- Industry partners and prospective collaborators

These conversations provided valuable insight into current market trends, emerging technologies, and future opportunities for collaboration.

Industry Topics Covered

The conference programme covered a wide range of subjects relevant to the future of medical cannabis, including:

- European medical cannabis regulations

- Pharmaceutical GMP standards

- International supply chains

- Patient access and healthcare delivery

- Product quality and safety

- Investment and market development

- Digital innovation in healthcare

These discussions highlighted the continued growth of the European market and the importance of maintaining high standards across every aspect of patient care.

Strengthening International Partnerships

One of the greatest benefits of attending ICBC Berlin was the opportunity to meet both existing and new industry partners in person.

Building strong relationships across the pharmaceutical and medical cannabis sectors is an important part of Crownz's long-term vision. Face-to-face discussions allow us to exchange ideas, better understand market needs, and identify opportunities that support the delivery of safe, compliant, and patient-focused healthcare services.

Looking Ahead

Events such as ICBC Berlin demonstrate how quickly the medical cannabis industry continues to evolve. Collaboration between healthcare providers, pharmaceutical companies, regulators, and technology businesses remains essential to improving patient access and maintaining the highest standards of care. We would like to thank the organisers and everyone we had the opportunity to meet during the conference. It was a pleasure to exchange ideas with so many professionals dedicated to advancing the medical cannabis sector. The insights and connections gained during ICBC Berlin 2026 will continue to support Crownz as we develop innovative healthcare solutions and prepare for the next stage of our journey. We look forward to attending future editions of ICBC Berlin and continuing to contribute to the growth of the global medical cannabis industry.